US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist

3.7181
-0.6519-14.92%

Trading Jan 8 13:20 ET

28.73MMarket Cap-0.62P/E (TTM)

Citius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Sep 30, 2024

(Q4)Sep 30, 2024

(Q3)Jun 30, 2024

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

2.96%-28.2M

13.05%-5.91M

12.68%-8.37M

0.85%-7.79M

-27.17%-6.14M

-2.46%-29.06M

-7.39%-6.8M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

Net income from continuing operations

-21.15%-39.43M

-11.40%-11.08M

-24.70%-10.57M

18.83%-8.54M

-156.88%-9.23M

3.26%-32.54M

-24.44%-9.94M

4.34%-8.48M

-39.21%-10.53M

61.05%-3.59M

Depreciation and amortization

7.87%209.61K

7.44%53.69K

7.82%52.85K

8.16%52.07K

8.10%51.01K

8.15%194.32K

8.04%49.97K

8.09%49.02K

8.26%48.14K

8.20%47.19K

Deferred tax

0.00%576K

0.00%144K

0.00%576K

-75.00%144K

--144K

Other non cash items

178.60%284.18K

--1

--109.95K

--98.08K

--76.15K

-73.03%102K

--0

----

Change In working capital

57.94%-1.69M

1,942.79%2.33M

52.94%-1.16M

-315.48%-2.61M

91.10%-233.46K

-1,772.40%-4.01M

-180.37%-126.19K

-2,508.46%-2.47M

136.24%1.21M

-174.32%-2.62M

-Change in inventory

---2.13M

----

--0

----

-Change in prepaid assets

81.23%-945.39K

2,302.82%1.26M

45.89%-1.08M

-183.52%-1.15M

100.97%25.01K

-4,430.59%-5.04M

8.15%-57.19K

-595.21%-2M

-2,083.45%-405.48K

-1,283.16%-2.58M

-Change in payables and accrued expense

84.98%1.54M

579.94%2.73M

39.55%-606.89K

-115.69%-377.13K

-10,541.30%-205.8K

23.99%832.86K

-35.15%-568.91K

-1,906.25%-1M

227.58%2.4M

-99.93%1.97K

-Change in other current liabilities

-10.86%-218.38K

-10.67%-57.15K

-10.93%-54.82K

-10.93%-53.74K

-10.92%-52.68K

-11.14%-196.99K

-10.93%-51.64K

-11.22%-49.42K

-11.22%-48.44K

-11.22%-47.49K

-Change in other working capital

-81.75%72.04K

-4.57%526.35K

-0.01%579.59K

----

374.60%394.73K

13.78%551.54K

19.70%579.67K

----

Cash from discontinued investing activities

Operating cash flow

2.96%-28.2M

13.05%-5.91M

12.68%-8.37M

0.85%-7.79M

-27.17%-6.14M

-2.46%-29.06M

-7.39%-6.8M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

Investing cash flow

Cash flow from continuing investing activities

-5M

Net other investing changes

---5M

----

Cash from discontinued investing activities

Investing cash flow

---5M

----

--0

----

Financing cash flow

Cash flow from continuing financing activities

-27.89%9.97M

-545,260.12%-3.75M

13.83M

-687

Net common stock issuance

0.04%13.8M

365.17%84.73K

----

--13.8M

---31.95K

----

Proceeds from stock option exercised by employees

--0

----

--31.27K

----

Net other financing activities

---3.83M

----

Cash from discontinued financing activities

Financing cash flow

-27.89%9.97M

-545,260.12%-3.75M

-0.58%13.72M

----

--13.83M

---687

--13.8M

----

Net cash flow

Beginning cash position

-36.51%26.48M

-46.18%17.91M

-56.79%12.56M

-44.84%20.35M

-36.51%26.48M

-40.47%41.71M

-30.73%33.28M

-47.87%29.07M

-43.62%36.89M

-40.47%41.71M

Current changes in cash

-52.51%-23.23M

-115.55%-14.66M

26.93%5.35M

0.46%-7.79M

-27.17%-6.14M

46.30%-15.23M

-7.40%-6.8M

154.67%4.22M

19.07%-7.82M

-3.72%-4.82M

End cash Position

-87.72%3.25M

-46.18%17.91M

-56.79%12.56M

-44.84%20.35M

-36.51%26.48M

-30.73%33.28M

-47.87%29.07M

-43.62%36.89M

Free cash flow

2.96%-28.2M

13.05%-5.91M

12.68%-8.37M

0.85%-7.79M

-27.17%-6.14M

-2.46%-29.06M

-7.39%-6.8M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Sep 30, 2024	(Q4)Sep 30, 2024	(Q3)Jun 30, 2024	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	2.96%-28.2M	13.05%-5.91M	12.68%-8.37M	0.85%-7.79M	-27.17%-6.14M	-2.46%-29.06M	-7.39%-6.8M	-24.25%-9.58M	18.75%-7.85M	-3.72%-4.82M
Net income from continuing operations	-21.15%-39.43M	-11.40%-11.08M	-24.70%-10.57M	18.83%-8.54M	-156.88%-9.23M	3.26%-32.54M	-24.44%-9.94M	4.34%-8.48M	-39.21%-10.53M	61.05%-3.59M
Depreciation and amortization	7.87%209.61K	7.44%53.69K	7.82%52.85K	8.16%52.07K	8.10%51.01K	8.15%194.32K	8.04%49.97K	8.09%49.02K	8.26%48.14K	8.20%47.19K
Deferred tax	0.00%576K	0.00%144K	0.00%144K	0.00%144K	0.00%144K	0.00%576K	-75.00%144K	--144K	--144K	--144K
Other non cash items	178.60%284.18K	--1	--109.95K	--98.08K	--76.15K	-73.03%102K	--0	--0	----	----
Change In working capital	57.94%-1.69M	1,942.79%2.33M	52.94%-1.16M	-315.48%-2.61M	91.10%-233.46K	-1,772.40%-4.01M	-180.37%-126.19K	-2,508.46%-2.47M	136.24%1.21M	-174.32%-2.62M
-Change in inventory	---2.13M	----	----	----	----	--0	----	----	----	----
-Change in prepaid assets	81.23%-945.39K	2,302.82%1.26M	45.89%-1.08M	-183.52%-1.15M	100.97%25.01K	-4,430.59%-5.04M	8.15%-57.19K	-595.21%-2M	-2,083.45%-405.48K	-1,283.16%-2.58M
-Change in payables and accrued expense	84.98%1.54M	579.94%2.73M	39.55%-606.89K	-115.69%-377.13K	-10,541.30%-205.8K	23.99%832.86K	-35.15%-568.91K	-1,906.25%-1M	227.58%2.4M	-99.93%1.97K
-Change in other current liabilities	-10.86%-218.38K	-10.67%-57.15K	-10.93%-54.82K	-10.93%-53.74K	-10.92%-52.68K	-11.14%-196.99K	-10.93%-51.64K	-11.22%-49.42K	-11.22%-48.44K	-11.22%-47.49K
-Change in other working capital	-81.75%72.04K	-4.57%526.35K	-0.01%579.59K	----	----	374.60%394.73K	13.78%551.54K	19.70%579.67K	----	----
Cash from discontinued investing activities
Operating cash flow	2.96%-28.2M	13.05%-5.91M	12.68%-8.37M	0.85%-7.79M	-27.17%-6.14M	-2.46%-29.06M	-7.39%-6.8M	-24.25%-9.58M	18.75%-7.85M	-3.72%-4.82M
Investing cash flow
Cash flow from continuing investing activities	-5M					0
Net other investing changes	---5M	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	---5M	----	----	----	----	--0	----	----	----	----
Financing cash flow
Cash flow from continuing financing activities	-27.89%9.97M	-545,260.12%-3.75M				13.83M	-687
Net common stock issuance	0.04%13.8M	365.17%84.73K	----	----	----	--13.8M	---31.95K	----	----	----
Proceeds from stock option exercised by employees	--0	----	----	----	----	--31.27K	----	----	----	----
Net other financing activities	---3.83M	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-27.89%9.97M	-545,260.12%-3.75M	-0.58%13.72M	----	----	--13.83M	---687	--13.8M	----	----
Net cash flow
Beginning cash position	-36.51%26.48M	-46.18%17.91M	-56.79%12.56M	-44.84%20.35M	-36.51%26.48M	-40.47%41.71M	-30.73%33.28M	-47.87%29.07M	-43.62%36.89M	-40.47%41.71M
Current changes in cash	-52.51%-23.23M	-115.55%-14.66M	26.93%5.35M	0.46%-7.79M	-27.17%-6.14M	46.30%-15.23M	-7.40%-6.8M	154.67%4.22M	19.07%-7.82M	-3.72%-4.82M
End cash Position	-87.72%3.25M	-87.72%3.25M	-46.18%17.91M	-56.79%12.56M	-44.84%20.35M	-36.51%26.48M	-36.51%26.48M	-30.73%33.28M	-47.87%29.07M	-43.62%36.89M
Free cash flow	2.96%-28.2M	13.05%-5.91M	12.68%-8.37M	0.85%-7.79M	-27.17%-6.14M	-2.46%-29.06M	-7.39%-6.8M	-24.25%-9.58M	18.75%-7.85M	-3.72%-4.82M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Heat List

Overall

No Data

Investment Theme

Top Gainers Yesterday

Intraday-6.71%